ASSESSMENT OF TISSUE PERMEABILITY ON DYNAMIC MAGNETIC CONTRAST ENHANCEMENT MAGNETIC RESONANCE IN PROSTATE CANCER DIAGNOSIS

Thị Thường Đào, Tuấn Linh Lê, Đình Âu Hoàng, Văn Sơn Đoàn

Main Article Content

Abstract

Purpose: The aims of this study was to evaluate tissue permeability on dynamic contrast-enhanced MRI in the diagnosis of prostate cancer (PC). Material and Methods: A cross-sectional descriptive study was conducted on 39 patients with suspected PC at Hanoi Medical University Hospital from April 2023 to July 2024. Patients underwent multiparametric prostate MRI with dynamic contrast-enhancement (DCE) pulse sequence to evaluate tissue permeability. Results: Of the total 39 patients enrolled in the study, 51.3% were diagnosed with PC and 48.7% were diagnosed with benign tumors. Most patients diagnosed with PC (95.0%) had limited DWI/ADC diffusion and early enhancement on DCE pulses (90%). Among the tissue permeability parameters, K-trans and Kep are two highly valuable parameters in the diagnosis of PC. At the cut-off of 0.382 for K-trans and 1.146 for Kep, the sensitivity and specificity were 90% and 94.2% for Ktrans, 95% and 94.7% for Kep, respectively. Conclusion: Tissue permeability parameters on dynamic contrast-enhancement MRI have high value in diagnosing prostate cancer.

Article Details

References

Merriel SWD, Pocock L, Gilbert E, et al. Systematic review and meta-analysis of the diagnostic accuracy of prostate-specific antigen (PSA) for the detection of prostate cancer in symptomatic patients. BMC Med. 2022;20(1):54. doi:10.1186/s12916-021-02230-y
2. Alghamdi D, Kernohan N, Li C, Nabi G. Comparative Assessment of Different Ultrasound Technologies in the Detection of Prostate Cancer: A Systematic Review and Meta-Analysis. Cancers (Basel). 2023;15(16): 4105. doi:10.3390/ cancers15164105
3. Giá trị cộng hưởng từ khuếch tán trong chẩn đoán ung thư tuyến tiền liệt | Hội Điện Quang và Y Học Hạt Nhân. April 1, 2017. Accessed July 20, 2023. https://www.radiology. com.vn/bao-cao-khoa-hoc/gia-tri-cong-huong-tu-khuech-tan-trong-chan-doan-ung-thu-tuyen-tien-liet-n379.html
4. Chatterjee A, He D, Fan X, et al. Performance of Ultrafast DCE-MRI for Diagnosis of Prostate Cancer. Acad Radiol. 2018;25(3):349-358. doi:10.1016/j.acra.2017.10.004
5. Xu S, Liu X, Zhang X, et al. Prostate zones and tumor morphological parameters on magnetic resonance imaging for predicting the tumor-stage diagnosis of prostate cancer. Diagn Interv Radiol. 2023; 29(6): 753-760. doi:10.4274/dir. 2023.232284
6. Ma XZ, Lv K, Sheng JL, et al. Application evaluation of DCE-MRI combined with quantitative analysis of DWI for the diagnosis of prostate cancer. Oncol Lett. 2019;17(3):3077-3084. doi:10.3892/ol.2019.9988
7. Zhang Y, Li Z, Gao C, et al. Preoperative histogram parameters of dynamic contrast‐enhanced MRI as a potential imaging biomarker for assessing the expression of Ki‐67 in prostate cancer. Cancer Med. 2021;10(13):4240-4249. doi:10.1002/cam4.3912
8. Sun H, Du F, Liu Y, Li Q, Liu X, Wang T. DCE-MRI and DWI can differentiate benign from malignant prostate tumors when serum PSA is ≥10 ng/ml. Front Oncol. 2022;12:925186. doi:10.3389/fonc.2022.925186